COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

COPD worsens over time and can be life threatening without treatment. More than 11.7 million ... When symptoms first occur, some people ignore them, thinking they’re related to something less ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

Pneuma Respiratory, a med-tech and pharmaceutical company dedicated to advancing inhaled respiratory therapeutics, is introducing new transformational approaches to respiratory health to improve the ...

Millions are affected by lung conditions, often unaware of risks. Asthma + Lung UK's Andy Whittamore shares tips for ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will recover. That isn't the case for many companies that have lagged broader ...

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read why I rate REGN a Buy.

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...